🎉 M&A multiples are live!
Check it out!

Vicapsys Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vicapsys and similar public comparables like Pharming, Benevolent AI, and Vivoryon Therapeutics.

Vicapsys Overview

About Vicapsys

Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.


Founded

1997

HQ

United States of America
Employees

2

Website

vicapsys.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$57.8M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Vicapsys Financials

Vicapsys has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Vicapsys achieved revenue of n/a and an EBITDA of -$1.2M.

Vicapsys expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Vicapsys valuation multiples based on analyst estimates

Vicapsys P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$0.6M -$1.2M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$0.2M -$1.0M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Vicapsys Stock Performance

As of April 15, 2025, Vicapsys's stock price is $2.

Vicapsys has current market cap of $57.3M, and EV of $57.8M.

See Vicapsys trading valuation data

Vicapsys Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$57.8M $57.3M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Vicapsys Valuation Multiples

As of April 15, 2025, Vicapsys has market cap of $57.3M and EV of $57.8M.

Vicapsys's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Vicapsys's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Vicapsys and 10K+ public comps

Vicapsys Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $57.8M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -49.7x XXX XXX XXX
P/E -48.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -138.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Vicapsys Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Vicapsys Valuation Multiples

Vicapsys's NTM/LTM revenue growth is n/a

Vicapsys's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.5M for the same period.

Over next 12 months, Vicapsys's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Vicapsys's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Vicapsys and other 10K+ public comps

Vicapsys Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 89% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Vicapsys Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Vicapsys M&A and Investment Activity

Vicapsys acquired  XXX companies to date.

Last acquisition by Vicapsys was  XXXXXXXX, XXXXX XXXXX XXXXXX . Vicapsys acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Vicapsys

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Vicapsys

When was Vicapsys founded? Vicapsys was founded in 1997.
Where is Vicapsys headquartered? Vicapsys is headquartered in United States of America.
How many employees does Vicapsys have? As of today, Vicapsys has 2 employees.
Is Vicapsys publicy listed? Yes, Vicapsys is a public company listed on PINX.
What is the stock symbol of Vicapsys? Vicapsys trades under VICP ticker.
Who are competitors of Vicapsys? Similar companies to Vicapsys include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Vicapsys? Vicapsys's current market cap is $57.3M
Is Vicapsys profitable? Yes, Vicapsys is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.